Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 03, 2025 08:00 ET | Source: Stratus Therapeutics, Inc.

Nobel Laureate Dr. Ardem Patapoutian Joins Stratus Scientific Advisory Board

Dr. Ardem Patapoutian, PhD, is a recipient of the Nobel Prize in Physiology or Medicine in 2021 for his work characterizing the PIEZO1 and PIEZO2 receptors that detect touch, pressure, and...
June 02, 2025 08:00 ET | Source: Stratus Therapeutics, Inc.

Stratus Therapeutics Strengthens Executive Team with Appointment of Michael P. Cooke, PhD as Chief Scientific Officer

CAMBRIDGE, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Stratus Therapeutics, Inc. (“Stratus”), a biotechnology company developing on-demand hematopoietic stem cell (HSC) therapies, today announced the...
May 22, 2025 08:00 ET | Source: Stratus Therapeutics, Inc.

Stratus Announces Publication of Stratus PRIME™ HSC Platform in the American Journal of Hematology

First-in-class approach enables the generation of transgene-free hematopoietic stem cells through mechanosensitive PIEZO1 activation Stratus has an exclusive license to the intellectual property for...
May 09, 2025 08:00 ET | Source: Stratus Therapeutics, Inc.

Garuda Therapeutics Announces Name Change to Stratus Therapeutics to Reflect Mission of Pioneering Full Hematopoietic System Renewal

CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Garuda Therapeutics (“Garuda”), a biotechnology company developing off-the-shelf hematopoietic stem cell (HSC) therapies, today announced that it...
March 04, 2025 07:30 ET | Source: Garuda Therapeutics

Garuda Therapeutics Closes $50 Million Series A-1 Financing to Advance Off-the-Shelf Blood Stem Cell Therapies

CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Garuda Therapeutics (Garuda), a biotechnology company creating off-the-shelf, HSC therapies for a multitude of blood disorders, today announced...
March 03, 2025 07:30 ET | Source: Garuda Therapeutics

Garuda Therapeutics Announces the Appointment of Avanish Vellanki as President and Chief Executive Officer

CAMBRIDGE, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- Garuda Therapeutics (Garuda), a biotechnology company pioneering off-the-shelf, blood stem cell therapies, today announced that its Board of...